105 related articles for article (PubMed ID: 15364180)
1. VALUE: analysis of results.
Sever P
Lancet; 2004 Sep 11-17; 364(9438):933-4; author reply 935. PubMed ID: 15364180
[No Abstract] [Full Text] [Related]
2. Angiotensin receptor blockers and myocardial infarction.
Verma S; Strauss M
BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
[No Abstract] [Full Text] [Related]
3. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
Sarzani R; Dessì-Fulgheri P
J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
[No Abstract] [Full Text] [Related]
4. Two amlodipine/ARB combinations for hypertension.
Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
[No Abstract] [Full Text] [Related]
5. Aliskiren/valsartan (Valturna) for hypertension.
Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
[No Abstract] [Full Text] [Related]
6. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
Nilsson PM
Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
[No Abstract] [Full Text] [Related]
7. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
[No Abstract] [Full Text] [Related]
8. Exforge HCT.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
[No Abstract] [Full Text] [Related]
9. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
[No Abstract] [Full Text] [Related]
10. Lithium intoxication after valsartan treatment.
Su YP; Chang CJ; Hwang TJ
Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
[No Abstract] [Full Text] [Related]
11. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
[No Abstract] [Full Text] [Related]
12. Fetal toxic effects and angiotensin-II-receptor antagonists.
Martinovic J; Benachi A; Laurent N; Daikha-Dahmane F; Gubler MC
Lancet; 2001 Jul; 358(9277):241-2. PubMed ID: 11480433
[No Abstract] [Full Text] [Related]
13. Angiotensin-II-receptor inhibitors in pregnancy.
Chung NA; Lip GY; Beevers M; Beevers DG
Lancet; 2001 May; 357(9268):1620-1. PubMed ID: 11386316
[No Abstract] [Full Text] [Related]
14. [Acute renal failure and hypertension].
Bellido D; Sánchez de la Nieta MD; Vozmediano C; Oteros R; Zarca MA; Nieto J; Rivera F
Nefrologia; 2005; 25(5):563-7. PubMed ID: 16392308
[TBL] [Abstract][Full Text] [Related]
15. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
[TBL] [Abstract][Full Text] [Related]
16. [AT1 receptor antagonists in treatment of hypertension].
Franz IW
Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
[No Abstract] [Full Text] [Related]
17. Second study on valsartan is threatened with retraction over alleged data manipulation.
Mahony C
BMJ; 2013 Aug; 347():f4920. PubMed ID: 23918698
[No Abstract] [Full Text] [Related]
18. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
[No Abstract] [Full Text] [Related]
19. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
Unger T
Fortschr Med; 1997 Aug; 115(24):42-3. PubMed ID: 9410822
[No Abstract] [Full Text] [Related]
20. Valsartan. Just a second-line antihypertensive drug.
Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]